Want to join the conversation?
Medical technology company $MDT said new clinical data from an endpoint in the RevElution Trial for next-generation Drug-Filled Stent showed rapid vessel healing without inflammation in Optical Coherence Tomography data of the complete one-month follow-up patient group. The stent is available for investigational use only outside of the US.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.